Dashboard
Manage Tickers

CRBP


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

corbus-pharmaceuticals-q3-eps-190-misses-172-estimate
Corbus Pharmaceuticals Q3 EPS $(1.90) Miss...
11/12/2025 13:08:39

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.90) per share which missed the analyst consensus estimate...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/31/2025 17:06:11

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/31/2025 12:10:20

roku-sps-commerce-newell-brands-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Roku, SPS Commerce, Newell Brands And Othe...
10/31/2025 12:09:18

why-amazon-shares-are-trading-higher-by-over-12-here-are-20-stocks-moving-premarket
Why Amazon Shares Are Trading Higher By Ov...
10/31/2025 09:31:59

corbus-pharmaceuticals-prices-75m-public-offering-of-4744231-common-stock-and-pre-funded-warrants-at-1300-per-share-to-advance-oncology-and-obesity-pipeline
Corbus Pharmaceuticals Prices $75M Public ...
10/31/2025 07:10:28

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/30/2025 21:07:13

corbus-pharmaceuticals-announces-proposed-public-offering-size-not-given
Corbus Pharmaceuticals Announces Proposed ...
10/30/2025 20:37:39

wedbush-maintains-outperform-on-corbus-pharmaceuticals-raises-price-target-to-38
Wedbush Maintains Outperform on Corbus Pha...
10/20/2025 13:16:48

Wedbush analyst Robert Driscoll maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and raises the price target...

hc-wainwright--co-reiterates-buy-on-corbus-pharmaceuticals-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on Corb...
10/20/2025 11:44:33

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and maintains...

reported-saturday-corbus-pharmaceuticals-presents-crb-701-data-at-european-society-for-medical-oncology-2025-showing-476-objective-response-rate-in-head-and-neck-squamous-cell-carcinoma-375-in-cervical-cancer-and-556-in-urothelial-tumors
Reported Saturday, Corbus Pharmaceuticals ...
10/20/2025 08:25:04

3.6 mg/kg dose generated ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in mUCCRB-701 continues to demonstrate a fav...

corbus-pharmaceuticals-releases-abstract-for-its-phase-12-oncology-study-ahead-of-presentation-at-esmo-congress-2025-abstract-includes-safety-data-from-70-participants
Corbus Pharmaceuticals Releases Abstract F...
10/14/2025 12:07:06

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical stage company focused on oncology and obesity, announced today t...

hc-wainwright--co-reiterates-buy-on-corbus-pharmaceuticals-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on Corb...
09/17/2025 10:26:46

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and maintains...

fda-grants-fast-track-designation-to-corbus-pharmaceuticals-nectin-4-for-head-and-neck-squamous-cell-carcinoma
FDA Grants Fast Track Designation To Corbu...
09/16/2025 12:01:48

oppenheimer-maintains-outperform-on-corbus-pharmaceuticals-lowers-price-target-to-53
Oppenheimer Maintains Outperform on Corbus...
08/06/2025 12:11:40

Oppenheimer analyst Jeff Jones maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and lowers the price target ...

corbus-pharmaceuticals-q2-eps-144-beats-152-estimate
Corbus Pharmaceuticals Q2 EPS $(1.44) Beat...
08/05/2025 12:36:43

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.44) per share which beat the analyst consensus estimate o...

corbus-pharmaceuticals-announces-that-an-abstract-on-updated-clinical-data-from-its-phase-12-clinical-study-of-crb-701-has-been-accepted-for-presentation-as-a-poster-at-the-european-society-for-medical-oncology--congress-2025--october-17-21-2025-in-berlin-germany
Corbus Pharmaceuticals Announces That An A...
07/30/2025 12:02:27

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical-stage company focused on oncology and obesity, announced today t...

Core News & Articles
Cannabis Stock Gainers And Losers From Jul...
07/16/2025 20:32:21

Core News & Articles
Cannabis Stock Movers For July 15, 2025
07/15/2025 20:30:09

Core News & Articles
Bullish Sentiment Across The Cannabis Spac...
07/09/2025 20:30:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION